BIOXIS PHARMACEUTICALS Trademark

Trademark Overview


On Wednesday, May 15, 2019, a trademark application was filed for BIOXIS PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the BIOXIS PHARMACEUTICALS trademark a serial number of 79265623. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, March 30, 2020. This trademark is owned by BIOXIS PHARMACEUTICALS. The BIOXIS PHARMACEUTICALS trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products and substances; dermatological products; pharmaceutical products for the treatment of acne, keratosis, seborrhea, psoriasis, signs and symptoms of photo-aging; products for the repair and healing of nerve endings; medical products for skin restoration and growth, namely, products injected in or under the skin, in or under mucous membranes, in or under adipose tissues for use as alternatives to a plastic surgery treatment and/or for filling, remodeling, increasing the volume of any part of the body and for skin regeneration; cartilage reconstruction product; disc hernia treatment product; vaccine vector product

Surgical, medical and veterinary apparatus and instruments; syringes for injection of dermatological products; suture material; implant of any kind and for any use and in particular general surgery implants, visceral and parietal surgery implants, implants for reconstructive and aesthetic surgery, cardiovascular implants, dental implants, orthopedic implants; biocompatible materials for medical use including visco-supplementation substances, designed to fill wrinkles and increase volume

Scientific and medical research; design and development of pharmaceutical and therapeutic products; consultancy with respect to the development of implants and prostheses; medical and scientific research in the field of pharmaceutical products
bioxis pharmaceuticals

General Information


Serial Number79265623
Word MarkBIOXIS PHARMACEUTICALS
Filing DateWednesday, May 15, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, March 30, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consist of the stylized wording "BIOXIS PHARMACEUTICALS".
Goods and ServicesPharmaceutical products and substances; dermatological products; pharmaceutical products for the treatment of acne, keratosis, seborrhea, psoriasis, signs and symptoms of photo-aging; products for the repair and healing of nerve endings; medical products for skin restoration and growth, namely, products injected in or under the skin, in or under mucous membranes, in or under adipose tissues for use as alternatives to a plastic surgery treatment and/or for filling, remodeling, increasing the volume of any part of the body and for skin regeneration; cartilage reconstruction product; disc hernia treatment product; vaccine vector product
Goods and ServicesSurgical, medical and veterinary apparatus and instruments; syringes for injection of dermatological products; suture material; implant of any kind and for any use and in particular general surgery implants, visceral and parietal surgery implants, implants for reconstructive and aesthetic surgery, cardiovascular implants, dental implants, orthopedic implants; biocompatible materials for medical use including visco-supplementation substances, designed to fill wrinkles and increase volume
Goods and ServicesScientific and medical research; design and development of pharmaceutical and therapeutic products; consultancy with respect to the development of implants and prostheses; medical and scientific research in the field of pharmaceutical products

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 30, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, August 30, 2019
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 30, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBIOXIS PHARMACEUTICALS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Sunday, April 18, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, March 30, 2021FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, March 30, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, February 13, 2021NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, January 27, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 27, 2021NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, March 30, 2020ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, March 30, 2020ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, October 5, 2019REFUSAL PROCESSED BY IB
Saturday, September 14, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, September 14, 2019REFUSAL PROCESSED BY MPU
Friday, September 6, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, September 5, 2019NON-FINAL ACTION WRITTEN
Tuesday, September 3, 2019APPLICATION FILING RECEIPT MAILED
Friday, August 30, 2019ASSIGNED TO EXAMINER
Friday, August 30, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 22, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB